IbidenLtd Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

IbidenLtd hat ein Gesamteigenkapital von ¥501.8B und eine Gesamtverschuldung von ¥396.4B, wodurch sich der Verschuldungsgrad auf 79% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen ¥1,130.0B bzw. ¥628.2B. IbidenLtd Das EBIT des Unternehmens beträgt ¥47.6B, so dass der Zinsdeckungsgrad -22.8 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von ¥443.6B.

Wichtige Informationen

79.0%

Verhältnis von Schulden zu Eigenkapital

JP¥396.42b

Verschuldung

Zinsdeckungsgrad	-22.8x
Bargeld	JP¥443.58b
Eigenkapital	JP¥501.80b
Gesamtverbindlichkeiten	JP¥628.20b
Gesamtvermögen	JP¥1.13t

Jüngste Berichte zur Finanzlage

Does IbidenLtd (TSE:4062) Have A Healthy Balance Sheet?

Mar 26

Recent updates

Ibiden Co.,Ltd. (TSE:4062) Looks Just Right With A 30% Price Jump

Jun 18

Is Now An Opportune Moment To Examine Ibiden Co.,Ltd. (TSE:4062)?

May 21

Ibiden Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 05

Ibiden Co.,Ltd.'s (TSE:4062) Earnings Haven't Escaped The Attention Of Investors

Apr 24

We Like These Underlying Return On Capital Trends At IbidenLtd (TSE:4062)

Apr 08

Does IbidenLtd (TSE:4062) Have A Healthy Balance Sheet?

Mar 26

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 4062Die kurzfristigen Aktiva des Unternehmens (¥600.8B) übersteigen seine kurzfristigen Passiva (¥358.4B).

Langfristige Verbindlichkeiten: 4062Die kurzfristigen Vermögenswerte des Unternehmens (¥600.8B) übersteigen seine langfristigen Verbindlichkeiten (¥269.8B).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 4062 über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: 4062Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 25.9% auf 79% gestiegen.

Schuldendeckung: 4062Die Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (36.6%).

Zinsdeckung: 4062 mehr Zinsen einnimmt als er zahlt, so dass die Deckung der Zinszahlungen kein Problem darstellt.

IbidenLtd Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Does IbidenLtd (TSE:4062) Have A Healthy Balance Sheet?

Recent updates

Ibiden Co.,Ltd. (TSE:4062) Looks Just Right With A 30% Price Jump

Full year 2024 earnings: EPS and revenues miss analyst expectations

Ibiden Co.,Ltd. to Report Q1, 2025 Results on Aug 02, 2024

Investor sentiment improves as stock rises 16%

Is Now An Opportune Moment To Examine Ibiden Co.,Ltd. (TSE:4062)?

High number of new directors

New minor risk - Share price stability

Ibiden Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

New minor risk - Profit margin trend

Full year 2024 earnings: EPS and revenues miss analyst expectations

Ibiden Co.,Ltd.'s (TSE:4062) Earnings Haven't Escaped The Attention Of Investors

We Like These Underlying Return On Capital Trends At IbidenLtd (TSE:4062)

Does IbidenLtd (TSE:4062) Have A Healthy Balance Sheet?

Upcoming dividend of JP¥20.00 per share

Ibiden Co.,Ltd. to Report Fiscal Year 2024 Results on May 01, 2024

Third quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Ibiden Co.,Ltd., Annual General Meeting, Jun 13, 2024

Now 22% undervalued

Ibiden Co.,Ltd. to Report Q3, 2024 Results on Feb 01, 2024

Now 22% undervalued after recent price drop

New major risk - Share price stability

Second quarter 2024 earnings: EPS exceeds analyst expectations

Now 21% undervalued after recent price drop

Upcoming dividend of JP¥20.00 per share at 0.5% yield

Ibiden Co.,Ltd. to Report Q2, 2024 Results on Oct 26, 2023

New major risk - Earnings quality

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 7.4% to JP¥8,722

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Price target increased by 7.4% to JP¥7,241

Investor sentiment improves as stock rises 17%

Ibiden Co.,Ltd. to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 18%

Consensus EPS estimates fall by 13%

Price target decreased by 7.2% to JP¥6,069

Upcoming dividend of JP¥20.00 per share at 0.8% yield

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Ibiden Co.,Ltd. to Report Q3, 2023 Results on Feb 02, 2023

Guangzhou Fastprint Investment Co., Ltd. agreed to acquire Ibiden Electronics (Beijing)Co.,Ltd. from Ibiden Co.,Ltd. (TSE:4062) for ¥17.7 billion.

Investor sentiment improved over the past week

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of JP¥20.00 per share

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Ibiden Co.,Ltd. to Report Q1, 2023 Results on Aug 02, 2022

Full year 2022 earnings: EPS misses analyst expectations

Investor sentiment deteriorated over the past week

Full year 2022 earnings: EPS misses analyst expectations

Ibiden Co.,Ltd. to Report Fiscal Year 2022 Results on Apr 27, 2022

Upcoming dividend of JP¥20.00 per share

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings released: EPS JP¥90.89 (vs JP¥50.73 in 2Q 2021)

Upcoming dividend of JP¥15.00 per share

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS JP¥68.51 (vs JP¥32.89 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥184 (vs JP¥81.08 in FY 2020)

Full year 2021 earnings released: EPS JP¥184 (vs JP¥81.08 in FY 2020)

Upcoming dividend of JP¥20.00 per share

Ibiden Co.,Ltd. to Report Fiscal Year 2021 Results on Apr 27, 2021

New 90-day low: JP¥4,455

Third quarter 2021 earnings released: EPS JP¥69.53 (vs JP¥30.67 in 3Q 2020)

Revenue and earnings beat expectations

New 90-day high: JP¥5,220

New 90-day high: JP¥5,110

Price target raised to JP¥4,941

New 90-day high: JP¥5,100

Price target raised to JP¥4,713

New 90-day high: JP¥5,020

Ibiden Co.,Ltd. to Report Q2, 2021 Results on Oct 28, 2020

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz